HTHHF - 4 Marijuana Stocks Looking to Start Strong on Friday (2/8/19)
CORAL GABLES, FL / ACCESSWIRE / February 8, 2019 / The marijuana stock market's success is largely dependent on several key factors. First of all, more lawmakers, on both a domestic and global scale, have advocated for legislation in favor of legalizing cannabis. As a result of the influx of legalization, the cannabis industry has managed to shift public opinion from a collective condemnation in past years, to a considerably more favorable outlook. As share prices rise, investors looking to the cannabis sector grow more excited and are hungry for companies looking for new and innovative ways to incorporate medicinal/recreational cannabis into the lives of consumers. If the cannabis sector continues to earn more public approval, companies in the space may see investors paying closer attention in the near future. Premier Health Group (OTC: PHGRF) (CSE: PHGI), Cronos Group Inc (NASDAQ: CRON, TSX: CRON), Tilray Inc (NASDAQ: TLRY), and Harvest Health & Recreation Inc (OTCQX: HTHHF) represent four pot stocks looking to close out a strong week.
Premier Health Group (OTC: PHGRF) (CSE: PHGI) is a company focused on developing innovative approaches that combine human skill-based expertise with state-of-the-art technologies used throughout the healthcare industry to create the best-possible care solutions for their growing patient network. The Company has seen impressive gains over the past few months following momentum gained from investing in advancements in telemedicine and artificial intelligence to make way for more nuanced health care solutions.
Premier Health Group (OTC: PHGRF) (CSE: PHGI) announced earlier this week that the Company is now formally entering the cannabis clinic space. Premier's recent acquisition of Cloud Practice Inc has provided an underlying platform to help empower and streamline patient-doctor interaction. Whereas other clinics typically struggle with the labor-intensive process of onboarding patients, this will be done automatically with Premier's smart EMR.
The healthcare professional need only identify patients who could benefit from medical cannabis, and Premier Health Group (OTC: PHGRF) (CSE: PHGI)'s integrated technology will assess the patient's data, and through the use of analytics, output a comprehensive recommendation along with links to corresponding research relevant to the diagnosis.
Dr. Essam Hamza, CEO of Premier Health Group (OTC: PHGRF) (CSE: PHGI), commented, "We are currently working on a partnership model to hard code the decision-making process into the Electronic Medical Records (EMR). There has been a critical gap between the patient's need for medical cannabis and the doctor's knowledge and comfort level in prescribing it. At Premier we understand the frustration felt from both the patient and the doctor and are integrating what we think is a revolutionary process. This new tool will allow us to provide a much-needed service to the 287 clinics and almost 3 million patients in our ecosystem."
For More Information On Premier Health Group, Click Here
Cronos Group Inc (CRON) has seen a month of favorable trading conditions as a result of the Company's announcement, back in December, that it had entered into a subscription agreement with Altria Group Inc, pursuant to which Altria has agreed to make n approximately C$2.4 billion equity investment in Cronos Group on a private placement basis in exchange for common shares in the spatial of the Company.
Later this month, the Company will be holding a special meeting of holders of common shares of the Company, at which time Shareholders will be asked to approve both the investment and other matters ancillary to the investment.
For More Information on Cronos Group Inc, Click Here
Tilray Inc (TLRY), a global leader in cannabis production, research, cultivation, and distribution, made an announcement earlier this week regarding the expansion of its global senior leadership team with the appointment of Sascha Mielcarek as Managing Director, Europe. Per the details of the appointment, Sascha Mielcarek comes to Tilray with over 18 years of experience in the pharmaceutical industry bringing extensive global commercial sales and marketing expertise in international markets such as the U.S., Europeand Latin America. Sascha most recently was at Grünenthal as Global Head of Gout Business Unit & Alliance Implementation Lead.
Brenden Kennedy, Tilray CEO, commented on the appointment, "Sascha brings an unmatched level of expertise from his years of experience in the European and global pharmaceutical industry and we're very pleased to welcome him to our team."
For More Information On Tilray Inc, Click Here
Harvest Health & Recreation Inc (HTHHF), a vertically integrated public cannabis company with one of the largest footprints in the U.S. cannabis market, announced earlier this month the appointment of John Cochran as the Company's new chief operating officer. Per the information provided from the announcement, Cochran formally served as CEO of several major companies, including multistage cannabis company Loudpack Inc, and Pabst Brewing Company.
Following the announcement, Harvest CEO Steve White stated, "John's proven track record with some of the largest and best known, multinational brands and companies will accelerate our growth as we aggressively expand into new markets. His cannabis experience is an added bonus."
For More Information On Harvest Health & Recreation Inc, Click Here
What Is Stock Price (StockPrice.com)?
Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for.
StockPrice.com was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.
At Stock Price (StockPrice.com), you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns www.StockPrice.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.
JSG Communications, LLC, which owns www.StockPrice.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns www.StockPrice.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.
Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 - 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 ( CASH) for & were paid "500,000" shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the "500,000" shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Please click here for full disclaimer.
Contact Information:
SOURCE: StockPrice.com